Skip to main content

#151291

Anti-MUS81 [MTA30 2G10/3]

Cat. #151291

Anti-MUS81 [MTA30 2G10/3]

Cat. #: 151291

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: MUS81

Class: Monoclonal

Application: IF ; ICC ; FACS ; IHC ; IF ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Stephen West

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-MUS81 [MTA30 2G10/3]
  • Research fields: Cancer;Genetics
  • Clone: MTA30 2G10/3
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 60-65 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IF ; ICC ; FACS ; IHC ; IF ; IP ; WB
  • Description: MUS81 and EME1 constitute a heterodimeric endonuclease that has been implicated in mitotic and meiotic recombination in eukaryotes.
  • Immunogen: Human MUS81
  • Isotype: IgG2a
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: MUS81
  • Molecular weight: 60-65 kDa
  • Target background: MUS81 and EME1 constitute a heterodimeric endonuclease that has been implicated in mitotic and meiotic recombination in eukaryotes.

Applications

  • Application: IF ; ICC ; FACS ; IHC ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Xu et al. 2019. Sci Adv. 5(10):eaax6366. PMID: 31633027.
  • Panier et al. 2019. Mol Cell. 76(1):27-43.e11. PMID: 31447390.
  • Mason et al. 2019. Nat Commun. 10(1):4410. PMID: 31562309.
  • Xu et al. 2017. Elife. 6:. PMID: 29106372.
  • Moder et al. 2017. Nat Commun. 8(1):1238. PMID: 29089570.
  • Lemaon et al. 2017. Nat Commun. 8(1):860. PMID: 29038425.
  • Li et al. 2017. Mol Med Rep. 16(4):5321-5325. PMID: 28849153.
  • Dungrawala et al. 2017. Mol Cell. 67(3):374-386.e5. PMID: 28735897.
  • Di Marco et al. 2017. Mol Cell. 66(5):658-671.e8. PMID: 28575661.
  • Lv et al. 2017. Tumour Biol. 39(3):1010428317694307. PMID: 28347251.
  • Wyatt et al. 2017. Mol Cell. 65(5):848-860.e11. PMID: 28257701.
  • Meisenberg et al. 2017. Nucleic Acids Res. 45(3):1159-1176. PMID: 28180300.
  • Meisenberg et al. 2017. Nucleic Acids Res. 45(3):1159-1176. PMID: 28180300.
  • Jo et al. 2016. PLoS Genet. 12(12):e1006465. PMID: 27906959.
  • Pepe et al. 2014. Nucleic Acids Res. 42(6):3833-45. PMID: 24371268.
  • CtIP is required to initiate replication-dependent interstrand crosslink repair.
  • Duquette et al. 2012. PLoS Genet. 8(11):e1003050. PMID: 23144634.
  • Svendsen et al. 2009. Cell. 138(1):63-77. PMID: 19596235.
  • Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair.
  • Franchitto et al. 2008. J Cell Biol. 183(2):241-52. PMID: 18852298.
  • Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.